The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study

To determine if 3% diquafosol (DQS) can preserve the meibomian gland morphology in glaucoma patients treated with prostaglandin analogs (PGA) for a 12-month follow-up period.
Source: BMC Ophthalmology - Category: Opthalmology Authors: Tags: Research article Source Type: research
More News: Glaucoma | Opthalmology | Study